Susan C Kandarian Selected Research

Atrophic Muscular Disorders

1/2012	The ChIP-seq-defined networks of Bcl-3 gene binding support its required role in skeletal muscle atrophy.
1/2012	Protein overexpression in skeletal muscle using plasmid-based gene transfer to elucidate mechanisms controlling fiber size.
1/2011	Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3.
2/2009	The IkappaB kinases IKKalpha and IKKbeta are necessary and sufficient for skeletal muscle atrophy.
10/2004	The molecular basis of skeletal muscle atrophy.
4/2002	Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan C Kandarian Research Topics

Disease

18	Atrophy 01/2017 - 04/2002
8	Muscular Atrophy (Muscle Atrophy) 01/2014 - 04/2002
6	Cachexia 12/2018 - 02/2007
6	Neoplasms (Cancer) 01/2017 - 01/2010
6	Atrophic Muscular Disorders 01/2012 - 04/2002
2	Carcinoma (Carcinomatosis) 01/2017 - 08/2015
2	Starvation 02/2007 - 04/2005
1	Lung Injury 01/2013
1	Heart Failure 01/2013
1	Stomach Neoplasms (Stomach Cancer) 01/2010
1	Inflammation (Inflammations) 04/2005
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2004

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 12/2014 - 10/2004
10	NF-kappa B (NF-kB)IBA 01/2014 - 04/2002
8	Transcription Factors (Transcription Factor)IBA 08/2015 - 10/2004
4	CytokinesIBA 08/2015 - 04/2002
4	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2014 - 08/2003
4	UbiquitinIBA 02/2007 - 10/2004
3	Interleukin-6 (Interleukin 6)IBA 08/2015 - 07/2012
2	Conditioned Culture MediaIBA 01/2017 - 08/2015
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2015 - 12/2014
2	NF-KappaB Inhibitor alphaIBA 01/2010 - 01/2007
2	Ligases (Synthetase)IBA 02/2007 - 02/2006
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 04/2005 - 08/2003
1	Biological ProductsIBA 01/2017
1	Blocking AntibodiesIBA 08/2015
1	Leukemia Inhibitory FactorIBA 08/2015
1	Messenger RNA (mRNA)IBA 01/2014
1	OligonucleotidesIBA 01/2014
1	Cytokine TWEAKIBA 07/2012
1	ChromatinIBA 01/2011
1	Trans-Activators (Trans-Acting Factor)IBA 01/2011
1	Phosphotransferases (Kinase)IBA 02/2009
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2007
1	Cathepsin LIBA 01/2007
1	Caspase 3 (Caspase-3)IBA 02/2006
1	Galectin 1 (LGALS1)IBA 04/2005
1	CCAAT-Enhancer-Binding Protein-betaIBA 04/2005
1	Complement System Proteins (Complement)IBA 04/2005
1	Peptide Initiation Factors (Initiation Factor)IBA 04/2005
1	Amino Acids FDA Link 04/2005
1	CathepsinsIBA 04/2005
1	CalpainIBA 10/2004
1	Muscle Proteins (Muscle Protein)IBA 10/2004
1	Serine Proteases (Serine Protease)IBA 08/2003

Therapy/Procedure

2	Therapeutics 12/2018 - 01/2017
2	Denervation 01/2013 - 02/2007